Table 2.
Echocardiographic parameters at baseline and 24 weeks
| Parameter | Baseline | 24 weeks | P value* | P value # | P value $ | ||
|---|---|---|---|---|---|---|---|
| Valsartan (n = 32) | Sac/Val (n = 32) | Valsartan (n = 32) | Sac/Val (n = 32) | ||||
| LA dimeter (cm) | 4.3 ± 0.5 | 4.3 ± 0.5 | 4.1 ± 0.4 | 3.8 ± 0.5 | 0.279 | <0.001 | 0.006 |
| RA dimeter (cm) | 4.2 ± 0.6 | 4.4 ± 0.8 | 4.2 ± 0.6 | 3.9 ± 0.7 | 0.951 | 0.017 | 0.053 |
| LAVi (mL/m2) | 46.8 ± 6.5 | 48.0 ± 6.4 | 45.3 ± 5.8 | 41.7 ± 7.0 | 0.356 | <0.001 | 0.027 |
| LVDd (cm) | 4.7 ± 0.6 | 4.9 ± 0.7 | 4.8 ± 0.5 | 4.9 ± 0.5 | 0.839 | >0.999 | 0.460 |
| RVDd (cm) | 3.6 ± 0.5 | 3.7 ± 0.7 | 3.6 ± 0.5 | 3.5 ± 0.5 | 0.963 | 0.244 | 0.565 |
| LVEF (%) | 60.6 ± 6.8 | 60.9 ± 6.6 | 62.8 ± 3.7 | 63.8 ± 5.0 | 0.115 | 0.054 | 0.332 |
LA, left atrial; RA, right atrial; LAVi, left atrial volume index; LVDd, left ventricle end‐diastolic diameter; LVEF, left ventricular ejection fraction; RVDd, right ventricle end‐diastolic diameter.
*
P < 0.05, valsartan group baseline versus 24 weeks after AF ablation.
#
P < 0.05, Sac/Val group baseline versus 24 weeks after AF ablation.
$
P < 0.05, valsartan group versus Sac/Val group at 24 weeks after AF ablation.